These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 29488227)

  • 41. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
    Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M
    J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
    Su TH; Liu CJ; Tseng TC; Liu CH; Yang HC; Chen CL; Chen PJ; Kao JH; Chen DS
    PLoS One; 2013; 8(2):e55916. PubMed ID: 23437072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.
    Watanabe K; Takahashi T; Takahashi S; Okoshi S; Ichida T; Aoyagi Y
    J Gastroenterol Hepatol; 2005 Mar; 20(3):441-9. PubMed ID: 15740490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region.
    Maruyama T; Mitsui H; Maekawa H; Yamada H; Hirayama M; Iino S; Yasuda K; Koike K; Kimura S; Milich DR
    Am J Gastroenterol; 2000 Oct; 95(10):2894-904. PubMed ID: 11051365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients.
    Choi JW; Ahn SH; Park JY; Chang HY; Kim JK; Baatarkhuu O; Kim DY; Han KH; Chon CY
    J Med Virol; 2009 Apr; 81(4):594-601. PubMed ID: 19235871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive role of early treatment dynamics of HBV RNA and HBcrAg for HBeAg seroconversion in children with chronic hepatitis B.
    Lai X; OuYang W; Li S; Qiu J; Zhang H; Jiang T; Qin X; Tang L; Gu Y; Yao Z; Peng S
    J Med Virol; 2024 May; 96(5):e29670. PubMed ID: 38773810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma.
    Ni YH; Chang MH; Wang KJ; Hsu HY; Chen HL; Kao JH; Yeh SH; Jeng YM; Tsai KS; Chen DS
    Gastroenterology; 2004 Dec; 127(6):1733-8. PubMed ID: 15578511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
    Krastev Z; Jelev D; Antonov K; Alagozian V; Kotzev I
    Hepatogastroenterology; 1999; 46(30):3184-8. PubMed ID: 10626183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of puberty onset on spontaneous hepatitis B virus e antigen seroconversion in men.
    Wu JF; Tsai WY; Hsu HY; Ni YH; Chen HL; Tsuei DJ; Chang MH
    Gastroenterology; 2010 Mar; 138(3):942-8.e1. PubMed ID: 19962986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age at time of hepatitis Be antibody seroconversion in childhood chronic hepatitis B infection and mutant viral strain detection rates.
    Ando T; Sugiyama K; Goto K; Miyake Y; Li R; Kawabe Y; Wada Y
    J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):583-7. PubMed ID: 10554127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection.
    Zhong YW; Di FL; Liu C; Zhang XC; Bi JF; Li YL; Wu SQ; Dong H; Liu LM; He J; Shi YM; Zhang HF; Zhang M
    Clin Microbiol Infect; 2016 Apr; 22(4):379.e1-379.e8. PubMed ID: 26577140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B.
    Liu CJ; Chen PJ; Lai MY; Lin FY; Wang T; Kao JH; Chen DS
    Liver Int; 2006 Oct; 26(8):949-55. PubMed ID: 16953835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
    Sonneveld MJ; Rijckborst V; Cakaloglu Y; Simon K; Heathcote EJ; Tabak F; Mach T; Boucher CA; Hansen BE; Zeuzem S; Janssen HL
    Antivir Ther; 2012; 17(1):9-17. PubMed ID: 22267464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe.
    Zhang K; Imazeki F; Fukai K; Arai M; Kanda T; Mikata R; Yokosuka O
    J Med Virol; 2007 Jun; 79(6):683-93. PubMed ID: 17457922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
    Yeh ML; Peng CY; Dai CY; Lai HC; Huang CF; Hsieh MY; Huang JF; Chen SC; Lin ZY; Yu ML; Chuang WL
    PLoS One; 2015; 10(4):e0122259. PubMed ID: 25835020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
    Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
    Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotype.
    Brunetto MR; Marcellin P; Cherubini B; Yurdaydin C; Farci P; Hadziyannis SJ; Rothe V; Regep L; Bonino F
    J Hepatol; 2013 Dec; 59(6):1153-9. PubMed ID: 23872601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients.
    Wang XL; Ren JP; Wang XQ; Wang XH; Yang SF; Xiong Y
    World J Gastroenterol; 2016 Mar; 22(11):3268-74. PubMed ID: 27004005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.